<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">Ischemia</z:e>-reperfusion injury in various organs has been discussed in connection with reactive oxygen species (ROS) </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="1" ids="15318,17712">Xanthine</z:chebi> oxidase (XOD) has been believed to be the source of <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> to produce this injury of dogs and rats but XOD is not detected in hearts of men, pigs or rabbits </plain></SENT>
<SENT sid="2" pm="."><plain>This suggests the importance of <z:chebi fb="38" ids="18421,29356">O2-</z:chebi> produced by leukocyte <z:chebi fb="0" ids="13392">NAD(P)H</z:chebi> oxidase </plain></SENT>
<SENT sid="3" pm="."><plain>We demonstrated in 1976 that 3 injections of Cu, Zn-SOD (<z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase) (i.v.) suppressed rat <z:chebi fb="0" ids="3435">carrageenan</z:chebi> paw <z:hpo ids='HP_0000969'>edema</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>McCord succeeded with a single injection in the same model using <z:chebi fb="1" ids="46793">polyethyleneglycol</z:chebi> (<z:chebi fb="77" ids="46793">PEG</z:chebi>-SOD) of long retention time in the blood stream </plain></SENT>
<SENT sid="5" pm="."><plain>Michelson's liposomal SOD had clinical effects on <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease, <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> etc </plain></SENT>
<SENT sid="6" pm="."><plain>Stylenemaleimide (SMA)-SOD (Inoue) is now under experimental trial and recombinant human SOD (r-h-SOD) is today in phase II stage </plain></SENT>
<SENT sid="7" pm="."><plain>The aim is to prevent myocyte damage or for kidney transplantation </plain></SENT>
<SENT sid="8" pm="."><plain>So-called SOD mimics (Cu-complex etc), <z:chebi fb="11" ids="22586">antioxidants</z:chebi> (synthetic <z:chebi fb="1" ids="26308">propyl</z:chebi> <z:chebi fb="0" ids="16918">gallate</z:chebi> or natural <z:chebi fb="5" ids="47916">flavonoids</z:chebi> or <z:chebi fb="47" ids="26848">tannins</z:chebi>) and <z:chebi fb="1" ids="29191">hydroxyl radical</z:chebi> (.OH) scavengers such as DMTU (dimethylthiourea) are considered as a prototype for clinical application </plain></SENT>
<SENT sid="9" pm="."><plain>Fe-<z:chebi fb="0" ids="38161">chelators</z:chebi> also attract attention, because Fe+2 produces the most reactive ROS, .OH radical </plain></SENT>
</text></document>